USAID To Provide $20M Over 5 Years To CEPI; Funds Subject To Congressional Approval

Homeland Preparedness News: USAID offers $20M in aid to CEPI for infectious diseases vaccine development
“The Coalition for Epidemic Preparedness Innovations (CEPI) gained a $20 million investment from the U.S. Agency for International Development (USAID) last week to support the development of vaccines targeting emerging infectious diseases. These funds will be provided over a five year period, subject to Congressional approval each year, to support CEPI’s development programs for several specific diseases, including Lassa fever, Middle Eastern Respiratory Syndrome, Nipah, Chikungunya, Rift Valley Fever, and Ebola…” (Galford, 10/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.